- Karin C. Lødrup Carlsen (N) Chair
- Vivi Schlunssen (DK)
- Knut Øymar (N)
- Maria Jernmalm (S)
- Nanna Fyhrquist (F)
- Sigurveig Sigurdardottir (IS)
Preliminary Scientific programme
This Nordic Allergy symposium reaches out to clinicians and researchers within all aspects of allergology, and the programme provides an excellent opportunity to discuss state of the art allergy practice in the Nordic countries. The highly profiled as well as up-and-coming young speakers come from all the Nordic countries as well as from EAACI.
1300-1700 The atopic march, pheno- and endotypes of allergic diseases
The pros, cons and implications of the atopic march
How important is IgE in allergic diseases?
Phenotypes, endotypes and allergies
Advances in Allergy diagnostics
BAT, MAT and beyond
CRD in allergy; clinical and diagnostic value
CRD in food allergy diagnosis
Discussion: when to use and not to use CRD?
News from EAACI
Anaphylaxis – new guidelines
1700 NFA General assembley and GET-TOGETHER
0830-1200 Nature and nurture: the microbiome and allergy development in "Norden"
Cutting edge: Host-microbe interactions in health and disease
The human microbiome and its impact on allergic disease
Microbiome- immune function
Environmental exposure, human health and allergies
Reducing the allergy burden in Nordic countries in 2019
The Finnish Allergy Programme 2008-2018: approaches and achievements
How Finland halved the number of children on allergen-free diets
1300-1800 Choosing Wisely in allergic disease
What is choosing wisely?
Modifiable factors in allergic disease, primary, secondary& tertiary prevention
Primary allergy prevention strategies in "Norden" in 2019
Epithelial barriers-basic concepts and role in primary prevention
Are skin interventions in infancy useful to reduce atopic dermatitis?
Nature-derived microbiome exposure to reduce allergic sensitisation
Secondary prevention; pipeline biologicals - Airways
Tertiary prevention of asthma: Allergen immunotherapy
0830-1300 Oral abstracts session - "Presenting young investigators in "Norden"
One from each country
Old diseases, new challenges?
Eosinophil oesophagitis an emerging epidemic?
Evidence based use of ICS doses during asthma exacerbations
Drug allergy during anaesthetics
The use of novel allergen immunotherapy in Nordic countries in 2020
AIT beyond SCIT/SLIT, available and pipe-line methods
Pollen allergens (adults and children)
Egg, milk OIT
1300 CLOSE and Lunch
Chair: Jon Olav Hunderi, Hospital trust Østfold. E-mail: email@example.com